Publications
- An orally active chemokine receptor CCR2 antagonists prevents glomerulosclerosis and renal failure in type 2diabetes. Commentary on:KI 80,2011,68-782011 | First Faculty of Medicine
- Clinical features, outcomes, and response to corticosteroid treatment of acute tubulointerstitial nephritis: a single centre retrospective cohort study in Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine
- Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitis2023 | First Faculty of Medicine
- Terapeutické možnosti blokády komplementu v léčbě atypického hemolyticko-uremického syndromu2023 | First Faculty of Medicine
- Biologická léčba u nemocných s AL amyloidózou2023 | First Faculty of Medicine
- Budesonid potvrdil efekt v léčbě IgA nefropatie ve studii NefIgArd: konec éry systémových kortikosteroidů?2023 | First Faculty of Medicine
- Biologická léčba u systémových amyloidóz2023 | First Faculty of Medicine
- Vybrané doporučené postupy v nefrologii2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Expert opinion on the cooperation of diabetologists and internists with nephrologists in the care of patients with chronic kidney diseases +12022 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis2022 | First Faculty of Medicine, Third Faculty of Medicine
Loading network view...